Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, TRI

Autism genetics study calls attention to impaired motor skills, general cognitive impairment


COLD SPRING HARBOR, N.Y., Feb. 7, 2018 /PRNewswire/ -- A new study of genetic factors involved causing autism spectrum disorders (ASD) draws fresh attention to the impact these illnesses have on motor skills, and more broadly on cognitive function.

Mutations that appear in a child which are not present in either parent?called de novo mutations?can be important in autism. Severe, gene-disrupting de novo mutations are thought to be capable of causing the disorder in certain instances. New research shows that diminished motor skills correlate with the severity of de novo mutations. More broadly the study calls attention to the role played by genetics in diminished cognitive functions in children across the autism spectrum.

"Diminished motor skills appear to be an almost universal property of children with autism," says Professor Michael Wigler, one of three researchers including Ivan Iossifov from Cold Spring Harbor Laboratory (CSHL) and the New York Genome Center, and Andreas Buja, a statistician from The University of Pennsylvania, who led the team.

Wigler adds that careful inference from the data suggests to him that the genetic factors causing ASD broadly diminish the brain's cognitive functions.  

These genetic factors are increasingly becoming known, are of two types: inherited mutations, and what scientists call de novo mutations. The latter are changes to DNA that don't appear in the genetic makeup of either parent and are new in the child. Damaging de novo mutations correlate with lower non-verbal IQ.  The new study finds that diminished motor skills also correlate significantly with de novo mutations in ASD.

The researchers find that the defining core behavioral components of ASD -- impaired social skills and communication -- do not correlate with the presence or severity of de novo mutations. A child with autism who has a severe de novo mutation is no more likely to have severely impaired social skills than is a child with autism for whom no such mutation was found, and who presumably has inherited causal factors. 

Restating: the researchers now think that children who have autism as a consequence of inherited factors have less general cognitive damage than those with severe de novo mutations.

This follows from Wigler's hypothesis that mutations with very damaging impact on human function will tend to be eliminated rapidly from the gene pool, since those affected are much less likely to have children.  In contrast, inherited factors involved in ASD that have "survived" in the genome for several generations are assumed to have a more restricted range of cognitive impact.

The near universality of diminished motor skills in ASD is an indicator that the factors that cause the core behavioral defects also cause general cognitive dysfunction, Professor Wigler explains. "As such, objective assessment of cognitive function should be a facet of any clinical evaluation of the patient," he says, "and included when monitoring therapeutic response."

This study was based on DNA sequence and deep phenotypic data from the Simons Simplex Collection, a set of 2,760 families that have a single child affected by ASD.

About Cold Spring Harbor Laboratory

Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. For more information, visit www.cshl.edu

SOURCE Cold Spring Harbor Laboratory


These press releases may also interest you

at 12:52
As part of Tampa General Hospital's (TGH) commitment to transforming health care through innovation, the academic health system collaborated with Manatee County and Archer First Response Systems (ArcherFRS) to accelerate response times to...

at 12:50
Today, Professor Francesco Muntoni, principal investigator of the international multicenter gene therapy trial for Duchenne Muscular Dystrophy with GNT0004 product, sponsored by Genethon, presented the innovative trial design and its initial results...

at 12:37
In this free webinar, attendees will gain insights into the clinical trial landscapes in China and Australia and discover practical strategies for maximizing collaboration and ensuring successful outcomes. This includes identifying common areas of...

at 12:36
Engage, Powered by ENA, on Tuesday announced a new partnership with Golisano Children's Hospital of Southwest Florida's emergency department that centers on enhancing the well-being and professional growth of emergency nurses who play an integral...

at 12:35
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and...

at 12:30
Concert Health, the leading Collaborative Care platform, and the Advancing Integrated Mental Health Solutions (AIMS) Center in the University of Washington Department of Psychiatry and Behavioral Sciences, today announced a three year, multi-state...



News published on and distributed by: